PharmSource is pleased to present our special 2015 INTERPHEX edition of Bio/Pharmaceutical Outsourcing Report. This monthly publication, brought to you by PharmSource’s experts, keeps you on top of the latest industry news, with analysis on its impact for the industry and on your business – critical information for helping you navigate in the contract services arena.
Bio/Pharmaceutical Outsourcing Report is just one of the great resources our STRATEGIC ADVANTAGE subscribers receive.
To receive a complimentary PDF copy of this special edition, please fill out this form:
Table of Contents
Commercial Dose Manufacturing and Packaging
• Aenova Expands Injectables Capacity, Consolidates Network
Commercial Dose Manufacturing and Packaging in Brief
Latest PharmSource Trend Reports
• CMO Scorecard: Outsourcing of NDA Approvals and CMO Performance
• Catching a Wave: How Much Will CMOs Benefit From Biosimilars?
• Opportunity Knocks: In-Licensed Drug Products Can Signal Outsourcing Opportunity
• CDMO and CRO Outlook: Robust Market Conditions Augur Growth
Clinical Dose Manufacturing and Packaging
• Catalent Expands Clinical Storage and 4 Packaging Capacity at German, UK 4 Facilities
Clinical Dose Manufacturing and Packaging in Brief
API — Large Molecule
• WuXi Doubles Down on Cell Therapy
API — Large Molecule in Brief
API — Small Molecule in Brief
• Flood of Money Buoys Service Providers